Related Experiment Video
Updated: Apr 26, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori and functional dyspepsia: an unsolved issue?
Angelo Zullo1, Cesare Hassan1, Vincenzo De Francesco1
1Angelo Zullo, Cesare Hassan, Gastroenterology and Digestive Endoscopy, "Nuovo Regina Margherita" Hospital, 00153 Rome, Italy.
Eradicating Helicobacter pylori (H. pylori) infection offers a small but significant improvement for some patients with functional dyspepsia. However, symptom relief varies, and the reasons for this inconsistency require further investigation.
Area of Science:
- Gastroenterology
- Microbiology
Background:
- Functional dyspepsia (FD) presents with dyspeptic symptoms despite normal gastroduodenal mucosa.
- The role of Helicobacter pylori (H. pylori) infection in FD pathogenesis is debated.
- H. pylori eradication shows a modest therapeutic benefit in some FD patients.
Purpose of the Study:
- To critically review trials on H. pylori eradication for functional dyspepsia.
- To explore reasons for inconsistent symptom improvement after H. pylori cure.
- To identify areas for future research in H. pylori and FD.
Main Methods:
- Critical review of existing clinical trials and meta-analyses.
- Analysis of study designs, symptom assessment, and potential biases.
- Synthesis of evidence regarding H. pylori eradication efficacy.
Main Results:
- H. pylori eradication provides a significant, albeit small (10%), therapeutic gain over placebo for dyspeptic symptoms.
- A substantial proportion of patients do not experience symptom resolution post-eradication.
- Inconsistencies in trial methodologies and outcome assessments limit definitive conclusions.
Conclusions:
- The benefit of H. pylori eradication in functional dyspepsia is confirmed but not universal.
- Variability in patient response necessitates further research into underlying mechanisms.
- Standardized trial designs are crucial for future investigations in this field.
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

